Project Details
| Short title | ARENA 303 |
|---|---|
| Acronym | ADVANCE-outcomes 303 |
| Status | Finished |
| Effective start/end date | 17/10/19 → 30/06/22 |
A phase 3 open-label extension (OLE) study to evaluate the long-term safety and efficacy of ralinepag in subjects with World Health Organisation (WHO) Group 1 pulmonary arterial hypertension (PAH): ADP811-303
- Brown, Martin (Primary Chief Investigator)
- Butala, Radhika (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research